Tuesday, November 18, 2008 3:21:16 PM
PL1, Thanks for posting yet another interesting and relevant article. It appears, increasingly, there is an enormous amount of important progress to be made, in Pharmacogenomics (also known as Personalized Medicine/Theranostics.) I'm glad that DNAPrint Genomics is one of a handful of companies, that is pioneering this field.
P.S., I currently own 198,411,787 shares of DNAG. (15.3% of outstanding shares.)
Daniel Gannon
Portland, Oregon, USA
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM